Actualités
This review article summarizes the currently available data within the field of transcatheter aortic valve/leaflet thrombosis and discusses the need for a patient tailored antithrombotic approach.
Although transcatheter aortic valve replacement (TAVR) therapy continues to grow, there have been concerns about the occurrence of hypoattenuating leaflet thickening (HALT), which may affect ...
The aim of this study was to use coronary computed tomography in patients with normal tricuspid aortic valves to perform detailed aortic root and aortic valve geometric analysis with a focus on the ...
Methods The Anticoagulation vs Dual Antiplatelet Therapy for Prevention of Leaflet Thrombosis and Cerebral Embolization after Transcatheter Aortic Valve Replacement(ADAPT-TAVR) trial is a multicenter, ...
WASHINGTON, DC—Subclinical leaflet thrombosis occurs “frequently” in patients who received bioprosthetic valves for the treatment of aortic stenosis, with the problem occurring more commonly in ...
Other suggestions? —D.A.M. ANSWER: The aortic valve, which separates the left ventricle from the aorta (the largest artery in the body), is supposed to have three leaflets. About 1 percent of ...
Certains résultats ont été masqués, car ils peuvent vous être inaccessibles.
Afficher les résultats inaccessibles